Add to ORKG[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0009-7322&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00017126560002
RATIONALE: Atherosclerotic lesion formation is associated with the accumulation of oxidized lipids....
Objective: We previously reported that Hemopexin (Hx), an acute phase protein and a heme scavenger, ...
Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against...
Objective—Using intravenous injection of adeno-associated viral (AAV) vectors based on novel serotyp...
Apolipoprotein E (apoE)-deficient mice develop marked hyperlipidemia as well as atherosclerosis and ...
Retardation of atherosclerosis in immunocompetent apolipoprotein (apo) E-deficient mice following li...
Abstract Background The atheroprotective effects of systemic delivery of either apolipoprotein A-I (...
BACKGROUND: Obesity is associated with vascular inflammation, fibrosis and reduced high-density lipo...
Although gene transfer of human apolipoprotein E (apoE), a 34-kDa circulating glycoprotein, to the l...
Apolipoprotein (apo) E, which is present in plasmalipoproteins that carry dietary and liver-derived ...
Background—The CC-chemokines (CKs) recruit monocytes/macrophages to sites of inflammation; several d...
BACKGROUND: The CC-chemokines (CKs) recruit monocytes/macrophages to sites of inflammation; several ...
The consequences of the lack of apolipoprotein A-I (apoA-I) were evaluated in mice made to lack apoA...
Recombinant adenovirus (rAd)-mediated apoE gene transfer to the liver of apoE(-/-) mice is anti-athe...
BACKGROUND: Mice deficient in apolipoprotein E (apoE(-/-)) develop atherosclerosis. The possible lin...
RATIONALE: Atherosclerotic lesion formation is associated with the accumulation of oxidized lipids....
Objective: We previously reported that Hemopexin (Hx), an acute phase protein and a heme scavenger, ...
Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against...
Objective—Using intravenous injection of adeno-associated viral (AAV) vectors based on novel serotyp...
Apolipoprotein E (apoE)-deficient mice develop marked hyperlipidemia as well as atherosclerosis and ...
Retardation of atherosclerosis in immunocompetent apolipoprotein (apo) E-deficient mice following li...
Abstract Background The atheroprotective effects of systemic delivery of either apolipoprotein A-I (...
BACKGROUND: Obesity is associated with vascular inflammation, fibrosis and reduced high-density lipo...
Although gene transfer of human apolipoprotein E (apoE), a 34-kDa circulating glycoprotein, to the l...
Apolipoprotein (apo) E, which is present in plasmalipoproteins that carry dietary and liver-derived ...
Background—The CC-chemokines (CKs) recruit monocytes/macrophages to sites of inflammation; several d...
BACKGROUND: The CC-chemokines (CKs) recruit monocytes/macrophages to sites of inflammation; several ...
The consequences of the lack of apolipoprotein A-I (apoA-I) were evaluated in mice made to lack apoA...
Recombinant adenovirus (rAd)-mediated apoE gene transfer to the liver of apoE(-/-) mice is anti-athe...
BACKGROUND: Mice deficient in apolipoprotein E (apoE(-/-)) develop atherosclerosis. The possible lin...
RATIONALE: Atherosclerotic lesion formation is associated with the accumulation of oxidized lipids....
Objective: We previously reported that Hemopexin (Hx), an acute phase protein and a heme scavenger, ...
Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against...